[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations]
- PMID: 22552550
[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations]
Abstract
Background: The etiology of acute exacerbations of chronic obstructive pulmonary disease (COPD) is heterogeneous and still under discussion. Inflammation increases during exacerbation of COPD. The identification of inflammatory changes will increase our knowledge and potentially guide therapy.
Aim: To identify which inflammatory parameters increase during COPD exacerbations compared to stable disease, and to compare bacterial and viral exacerbations.
Material and methods: In 85 COPD patients (45 males, mean age 68 ± 8 years, FEV1 46 ± 17% of predicted) sputum, nasopharyngeal swabs and blood samples were collected to identify the causative organism, during a mild to moderate exacerbation. Serum ultrasensitive C reactive protein (CRP), fibrinogen and interleukin 6 (IL 6), neutrophil and leukocyte counts were measured in stable conditions, during a COPD exacerbation, 15 and 30 days post exacerbation.
Results: A total of 120 mild to moderate COPD exacerbations were included. In 74 (61.7%), a microbial etiology could be identified, most commonly Mycoplasma pneumoniae (15.8%), Rhinovirus (15%), Haemophilus influenzae (14.2%), Chlamydia pneumoniae (11.7%), Streptococcus pneumoniae (5.8%) and Gram negative bacilli (5.8%). Serum CRP, fibrinogen and IL 6, and neutrophil and leukocyte counts significantly increased during exacerbation and recovered at 30 days post exacerbation. Compared to viral exacerbations, bacterial aggravations were associated with a systemic inflammation of higher magnitude.
Conclusions: Biomarkers of systemic inflammation increase during mild to moderate COPD exacerbations. The increase in systemic inflammation seems to be limited to exacerbations caused by bacterial infections.
Similar articles
-
Inflammatory changes, recovery and recurrence at COPD exacerbation.Eur Respir J. 2007 Mar;29(3):527-34. doi: 10.1183/09031936.00092506. Epub 2006 Nov 15. Eur Respir J. 2007. PMID: 17107990
-
Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25926728 Free PMC article.
-
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13. Am J Respir Crit Care Med. 2008. PMID: 18079493
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.Curr Opin Pulm Med. 2009 Mar;15(2):120-5. doi: 10.1097/MCP.0b013e3283218603. Curr Opin Pulm Med. 2009. PMID: 19532026 Review.
Cited by
-
Can mean platelet volume and neutrophil-to-lymphocyte ratio be biomarkers of acute exacerbation of bronchiectasis in children?Cent Eur J Immunol. 2017;42(4):358-362. doi: 10.5114/ceji.2017.72808. Epub 2017 Dec 30. Cent Eur J Immunol. 2017. PMID: 29472813 Free PMC article.
-
Hypercoagulable State in COPD-A Comprehensive Literature Review.Diagnostics (Basel). 2021 Aug 10;11(8):1447. doi: 10.3390/diagnostics11081447. Diagnostics (Basel). 2021. PMID: 34441381 Free PMC article. Review.
-
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.Thorax. 2013 Jul;68(7):670-6. doi: 10.1136/thoraxjnl-2012-201871. Epub 2012 Jun 28. Thorax. 2013. PMID: 22744884 Free PMC article. Review.
-
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3. Infection. 2020. PMID: 31482316
-
Role of metformin in treatment of patients with chronic obstructive pulmonary disease: a systematic review.J Thorac Dis. 2019 Oct;11(10):4371-4378. doi: 10.21037/jtd.2019.09.84. J Thorac Dis. 2019. PMID: 31737323 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous